Literature DB >> 36254079

Endoscopic findings of gastric neoplasms in familial adenomatous polyposis are associated with the phenotypic variations and grades of dysplasia.

Mayu Kobashi1, Masaya Iwamuro1, Sakiko Kuraoka1, Shoko Inoo1, Shotaro Okanoue1, Takuya Satomi1, Kenta Hamada1, Makoto Abe1, Yoshiyasu Kono1, Hiromitsu Kanzaki1, Seiji Kawano1, Takehiro Tanaka2, Yoshiro Kawahara3, Hiroyuki Okada1.   

Abstract

Patients with familial adenomatous polyposis (FAP) are at increased risk of developing gastric neoplasms. However, endoscopic findings have not been sufficiently investigated. We investigated the phenotypic expression of gastric adenoma (low-grade dysplasia) and gastric cancer (high-grade dysplasia or carcinoma) in patients with FAP and clarified their relationships to endoscopic findings. Of 29 patients with FAP who underwent esophagogastroduodenoscopy between 2005 and 2020, 11 (38%) had histologically confirmed gastric neoplasms, including 23 lesions of gastric adenoma and 9 lesions of gastric cancer. The gastric neoplasms were classified into 3 phenotypes (gastric, mixed, or intestinal type) according to the immunostaining results and evaluated for location (U or M region: upper or middle third of the stomach or L region: lower third of the stomach), color (same as the background mucosa, whitish, or reddish), macroscopic type (elevated, flat, or depressed), background mucosal atrophy (present or absent), fundic gland polyps in the surrounding mucosa (present or absent), and morphologic changes in tumor size. Elevated whitish gastric adenomas were further subdivided by macroscopic type (flat elevated, protruded, or elevated with a central depression) and color (milky- or pinkish-white). The gastric adenomas included gastric (11/23, 48%), mixed (4/23, 17%), and intestinal (8/23, 35%) phenotypes. In contrast, no lesions of gastric cancers showed a gastric phenotype (0/9, 0%), while 5 (56%) and 4 (44%) lesions were intestinal and mixed phenotypes, respectively. Gastric cancers were significantly more likely than gastric adenomas to present as reddish depressed lesions with gastric atrophy. All gastric-type adenomas occurred in non-atrophic mucosa, in mucosa with fundic gland polyps in the periphery, in the U or M region, and as flat elevated or protruded lesions with a milky-white color. Half of the lesions increased in size. Meanwhile, the typical endoscopic features of intestinal-type adenomas included occurrence in the L region and elevated pinkish-white lesions with central depression. None of the intestinal-type adenomas increased in size during the observation period. We believe that these endoscopic features will be useful for the prompt diagnosis and appropriate management of gastric neoplasms in patients with FAP.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2022        PMID: 36254079      PMCID: PMC9575760          DOI: 10.1097/MD.0000000000030997

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  30 in total

1.  Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps.

Authors:  R G Sarre; A G Frost; D G Jagelman; R E Petras; M V Sivak; E McGannon
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

Review 2.  Gastric cancer in FAP: a concerning rise in incidence.

Authors:  Gautam Mankaney; Pamela Leone; Michael Cruise; Lisa LaGuardia; Margaret O'Malley; Amit Bhatt; James Church; Carol A Burke
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

3.  Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.

Authors:  J Q Huang; S Sridhar; Y Chen; R H Hunt
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

Review 4.  The pathology of hereditary polyposis syndromes.

Authors:  Marco Novelli
Journal:  Histopathology       Date:  2015-01       Impact factor: 5.087

5.  Phenotypic variations of gastric neoplasms in familial adenomatous polyposis are associated with endoscopic status of atrophic gastritis.

Authors:  Kaoru Nakano; Hiroshi Kawachi; Akiko Chino; Mizuho Kita; Masami Arai; Daisuke Ide; Shoichi Saito; Shoichi Yoshimizu; Yusuke Horiuchi; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Tomohiro Tsuchida; Junko Fujisaki
Journal:  Dig Endosc       Date:  2019-10-31       Impact factor: 7.559

6.  Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis.

Authors:  S Nakamura; T Matsumoto; Y Kobori; M Iida
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

7.  Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology.

Authors:  K Komoto; K Haruma; T Kamada; S Tanaka; M Yoshihara; K Sumii; G Kajiyama; N J Talley
Journal:  Am J Gastroenterol       Date:  1998-08       Impact factor: 10.864

8.  Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology.

Authors:  Susan C Abraham; Elizabeth A Montgomery; Vikesh K Singh; John H Yardley; Tsung-Teh Wu
Journal:  Am J Surg Pathol       Date:  2002-10       Impact factor: 6.394

9.  Gastric neoplasms in patients with familial adenomatous polyposis: endoscopic and clinicopathologic features.

Authors:  Yusaku Shimamoto; Shingo Ishiguro; Yoji Takeuchi; Shin-Ichi Nakatsuka; Hiroshi Yunokizaki; Yasumasa Ezoe; Takeshi Nakajima; Kenshi Matsuno; Hiroko Nakahira; Kumiko Tanaka; Ryu Ishihara; Tetsuji Takayama; Teruhiko Yoshida; Hideki Ishikawa
Journal:  Gastrointest Endosc       Date:  2021-06-17       Impact factor: 9.427

10.  Genetic alteration of colorectal adenoma-carcinoma sequence among gastric adenocarcinoma and dysplastic lesions in a patient with attenuated familial adenomatous polyposis.

Authors:  Hiroki Tanabe; Kentaro Moriichi; Keitaro Takahashi; Yusuke Ono; Yu Kobayashi; Yuki Murakami; Takuya Iwama; Takehito Kunogi; Takahiro Sasaki; Katsuyoshi Ando; Nobuhiro Ueno; Shin Kashima; Hidehiro Takei; Yusuke Mizukami; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Mol Genet Genomic Med       Date:  2020-06-16       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.